Skip to main content
Clinical Trials/PACTR202307516307701
PACTR202307516307701
Not Yet Recruiting
Phase 1

Effects of a 10-week WalkWithMe application program on walking-related physical activity levels among community dwelling stroke survivors: a randomized controlled trial in Benin.

A0 sites54 target enrollmentFebruary 8, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Nervous System Diseases
Sponsor
A
Enrollment
54
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • Chronic stage of adults stroke at least 6 months after stroke onset
  • Absence of cognitive impairment and dementia
  • Ability to walk independently or with assistive devise, outside home during at least 10 min with gait velocity vary from 24 m/min (0\.4m/s) to 79 m/min (1\.3m/s), based on community ambulation measures
  • Not undergoing any form of rehabilitation or other physical treatment at intervention period;
  • Ability of the patient or a family caregiver to use modern technology.

Exclusion Criteria

  • Contraindication to physical exercise;
  • Other permanent or progressive neurological pathologies interfering walking such as hip prosthesis, rheumatoid arthritis.

Outcomes

Primary Outcomes

Not specified

Similar Trials